Clinical Trials in the Wake of COVID-19
ACT’s Lisa Henderson interviews John Potthoff, PhD, CEO of Elligo Health Research, about decentralizing and restarting clinical trials amid the COVID-19 pandemic.
Elevating Clinical Research with Technology Solutions
eCOA IRT Thought Leadership Series
2 Commerce Drive Cranbury, NJ 08512